Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy
PT Truong, IA Olivotto, TJ Whelan, M Levine - Cmaj, 2004 - Can Med Assoc
Objective: To provide information and recommendations to assist women with breast cancer
and their physicians in making decisions regarding the use of locoregional post-mastectomy …
and their physicians in making decisions regarding the use of locoregional post-mastectomy …
[HTML][HTML] Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant …
BS Abdulkarim, J Cuartero, J Hanson… - Journal of Clinical …, 2011 - ncbi.nlm.nih.gov
Purpose To evaluate the risk of locoregional recurrence (LRR) associated with locoregional
treatment of women with primary breast cancer tumors negative for estrogen receptor …
treatment of women with primary breast cancer tumors negative for estrogen receptor …
[PDF][PDF] Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer
Z Gabos, R Sinha, J Hanson, N Chauhan… - Journal of Clinical …, 2006 - academia.edu
Purpose As survival in breast cancer patients is improving, brain metastases are becoming
increasingly prevalent. The risk of brain metastases in newly diagnosed human epidermal …
increasingly prevalent. The risk of brain metastases in newly diagnosed human epidermal …
Placing the boost in breast-conservation radiotherapy: a review of the role, indications and techniques for breast-boost radiotherapy
P Graham, A Fourquet - Clinical Oncology, 2006 - Elsevier
Randomised trials have established that the addition of a boost dose of radiotherapy to the
lumpectomy site after whole-breast adjuvant radiotherapy further improves local control …
lumpectomy site after whole-breast adjuvant radiotherapy further improves local control …
The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer
Z Gabos, J Thoms, S Ghosh, J Hanson… - Breast cancer research …, 2010 - Springer
We investigated the association between the risk of locoregional recurrence (LRR) and
biological subtypes defined by hormonal receptors (HR) and HER-2 status in women with …
biological subtypes defined by hormonal receptors (HR) and HER-2 status in women with …
A population-based study of the fractionation of postlumpectomy breast radiation therapy
A Ashworth, W Kong, T Whelan, WJ Mackillop - International Journal of …, 2013 - Elsevier
PURPOSE: The optimal fractionation schedule of post lumpectomy radiation therapy
remains controversial. The objective of this study was to describe the fractionation of post …
remains controversial. The objective of this study was to describe the fractionation of post …
Consistency in seroma contouring for partial breast radiotherapy: impact of guidelines
EK Wong, PT Truong, HA Kader, AM Nichol… - International Journal of …, 2006 - Elsevier
Purpose: Inconsistencies in contouring target structures can undermine the precision of
conformal radiation therapy (RT) planning and compromise the validity of clinical trial …
conformal radiation therapy (RT) planning and compromise the validity of clinical trial …
[HTML][HTML] DEGRO practical guidelines for radiotherapy of breast cancer I
ML Sautter-Bihl, W Budach, J Dunst, P Feyer… - Strahlentherapie und …, 2007 - infona.pl
Background: The present paper is an update of the practical guidelines for radiotherapy of
breast cancer published in 2006 by the breast cancer expert panel of the German Society of …
breast cancer published in 2006 by the breast cancer expert panel of the German Society of …
PTHrP, a biomarker for CNS metastasis in triple-negative breast cancer and selection for adjuvant chemotherapy in node-negative disease
G Assaker, A Camirand, B Abdulkarim… - JNCI cancer …, 2020 - academic.oup.com
Background Triple-negative breast cancer (TNBC) is characterized by poor prognosis and
lack of targeted therapies and biomarkers to guide decisions on adjuvant chemotherapy …
lack of targeted therapies and biomarkers to guide decisions on adjuvant chemotherapy …
[HTML][HTML] Lin28 mediates radiation resistance of breast cancer cells via regulation of caspase, H2A. X and Let-7 signaling
L Wang, C Yuan, K Lv, S Xie, P Fu, X Liu, Y Chen… - PloS one, 2013 - journals.plos.org
Resistance to radiation therapy is a major obstacle for the effective treatment of cancers.
Lin28 has been shown to contribute to breast tumorigenesis; however, the relationship …
Lin28 has been shown to contribute to breast tumorigenesis; however, the relationship …